Glaucocalyxin B Attenuates Ovarian Cancer Cell Growth and Cisplatin Resistance In Vitro via Activating Oxidative Stress

Ovarian cancer is one of the fatal gynecological cancers around the world. Cisplatin is the first-line chemotherapy drug for the clinical treatment of ovarian cancer. However, many patients with ovarian cancer are still suffering from resistance to cisplatin. Therefore, the new drug combinations or...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tingting, Xu, Chenxin, Zheng, Peisen, Zhang, Xiaoxian, Qiu, Chenyu, Wu, Fengjiao, Chen, Jundixia, Xiao, Zhongxiang, Zhu, Jiandong, Zhang, Jingjing, Zou, Peng, Ni, Daoyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896941/
https://www.ncbi.nlm.nih.gov/pubmed/35251480
http://dx.doi.org/10.1155/2022/6324292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896941/
https://www.ncbi.nlm.nih.gov/pubmed/35251480
http://dx.doi.org/10.1155/2022/6324292

Ejemplares similares